Research

New Breast Cancer Drug on the Horizon?

Posted by  | Research

In today's news, updated data on an experimental breast cancer drug called trastuzumab emtansine, or T-DM1, shows better survival (by five months) than a standard mix of two other drugs for metastatic breast cancer patients.  We've talked often on this blog about the importance of taking these incremental steps toward finding the best cocktail of(...)

Cancer News Review

Posted by  | Research

This month, Kimmel Cancer Center director William Nelson reviewed top stories in cancer research ranging from a partnership between a pharmaceutical company and a major academic health center, to new ways to deliver the drug Herceptin. First, he discusses the recent partnership between pharmaceutical company, Novartis, and an academic health center, the University of Pennsylvania.(...)

The Data

Posted by  | Research

The following post was written by Jason Cherish, a colorectal cancer patient on his CaringBridge Journal page regarding his treatment and involvement with Swim Across America Baltimore. "I am really going to miss my chemotherapy treatments," said nobody. Ever. Having said that, I am very fortunate to be undergoing these treatments for my diagnosis, colorectal(...)

Cancer News Review

Posted by  | Research

In this month's Cancer News Review podcast, Dr. William Nelson, director of the Johns Hopkins Kimmel Cancer Center discusses the top stories in cancer research.  First, he discusses recent news of DNA sequencing efforts in leukemia.  As the availability of genome sequencing technology grows, we can inventory all of the acquired defects that contribute to cancer, he says. Finding(...)

Cancer News Review

Posted by  | Research

Cancer headlines this past month included two studies on colonoscopy, a screening tool for colon cancer.  The first study looks at the long-term benefits of colonoscopy and found that 50 percent of colon cancer cases were avoided by a single colonscopy.  In the Cancer News Review podcast, William Nelson, M.D., Ph.D., director of the Johns Hopkins Kimmel Cancer(...)

Cancer News Review

Posted by  | Research

Prostate cancer topics abound in the latest Cancer News Review podcast.  Dr. Bill Nelson, director of the Johns Hopkins Kimmel Cancer Center, discusses Hopkins-led research, published in the New England Journal of Medicine, looking at the genetic similarities of men with a family history of prostate cancer. By looking at their genes, investigators were able to find a genetic marker for(...)

More Good News on Melanoma Drug

Posted by  | Issues & Perspectives, Research, treatment

Researchers from the Vanderbilt-Ingram Cancer Center and other institutions reported more data today on studies of a new melanoma drug that target products of a cancer-causing mutation in the BRAF gene. The study, published in the New England Journal of Medicine, tracked patients with metastatic melanoma who have been followed for more than a year(...)

Creativity Competition Creates New Ideas to Cure Cancer

Posted by  | Research

Last Friday, the historic Hurd Hall at Johns Hopkins was filled to capacity with students, faculty and staff waiting to hear five scientists – all in the early part of their careers – describe their novel ideas on how to cure metastatic cancer.  It was part of a competition on creative thinking named for John(...)

Top Trends in Cancer Research 2011

Posted by  | Prevention/Screening, Research

It's been a game-changing year in cancer research.  Doctors and scientists don't typically like to use those words, but here's why I think this is a turning point.  Scientists are churning out the genetic code of cancer cells as quickly as the cost of sequencing technology plummets.   Teams of researchers are looking for ways to add the new armory of cancer cell-targeted(...)